4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adhami, N; Benowitz, N; Curras-Collazo, M; Destaillats, H; Dhall, S; Egiebor, I; Frankos, M; Garcia, M; Goodwin, B; Green, HW; Gundel, LA; Havel, C; Hovell, M; Jacob, P; Liles, S; Lyubovitsky, J; Martinez, B; Martins-Green, M; Matt, G; Sleiman, M; Valdez, M; Winickoff, JP; Yu, L | 1 |
1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Cigarette smoke toxins deposited on surfaces: implications for human health.
Topics: Animals; Biomarkers; Child, Preschool; Collagen; Fatty Liver; Humans; Infant; Liver; Lung; Maze Learning; Mice; Mice, Inbred C57BL; Nitrosamines; Non-alcoholic Fatty Liver Disease; Psychomotor Agitation; Pulmonary Fibrosis; Pyridines; Skin; Tobacco Smoke Pollution; Wound Healing | 2014 |